The IPO Buzz: Cancer-Focused Tempus AI (TEM Proposed) Leads $616 Million Week
Tempus AI (TEM Proposed), known for its proprietary AI-driven healthcare data platform, leads the IPO Calendar for the second week of June with its $400 million IPO. The unprofitable cancer-focused genomics testing and data company’s IPO is the only big IPO on this week’s lineup. Tempus AI is backed by SoftBank Corp. of Japan. Australia’s […]
June 9, 2024 Read More